Patents by Inventor Denver Lough

Denver Lough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000629
    Abstract: Provided herein are constructs of micro-aggregate multicellular, minimally polarized grafts containing Leucine-rich repeat-containing G-protein coupled Receptor (LGR) expressing cells for wound therapy applications, tissue engineering, cell therapy applications, regenerative medicine applications, medical/therapeutic applications, tissue healing applications, immune therapy applications, and tissue transplant therapy applications which preferably are associated with a delivery vector/substrate/support/scaffold for direct application.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: May 11, 2021
    Assignee: PolarityTE, Inc.
    Inventor: Denver Lough
  • Publication number: 20190328933
    Abstract: Disclosed herein is a composition comprising stimulated biological material derived from an interface compartment, wherein the composition is capable of augmenting the generation or healing of a native tissue when administered to a subject in need thereof.
    Type: Application
    Filed: July 10, 2019
    Publication date: October 31, 2019
    Inventors: Denver Lough, Nikolai Sopko, Pratima Labroo, Nicholas William Baetz, Jennifer Jensen Irvin, Georgia Crystal Yalanis, Matthew Petney
  • Publication number: 20190231927
    Abstract: Disclosed herein is a composition comprising stimulated biological material derived from an interface compartment, wherein the composition is capable of augmenting the generation or healing of a native tissue when administered to a subject in need thereof.
    Type: Application
    Filed: January 28, 2019
    Publication date: August 1, 2019
    Inventors: Denver Lough, Nikolai Sopko, Pratima Labroo, Nicholas William Baetz, Jennifer Jensen Irvin, Georgia Crystal Yalanis, Matthew Petney
  • Publication number: 20190231932
    Abstract: Disclosed herein is a composition comprising a stimulated heterogeneous mammalian tissue interface cell aggregate that is capable of producing functional polarized tissue when administered to a subject in need thereof.
    Type: Application
    Filed: January 28, 2019
    Publication date: August 1, 2019
    Inventors: Denver Lough, Nikolai Sopko, Pratima Labroo, Nicholas Baetz
  • Publication number: 20190059861
    Abstract: Kits and methods are provided for harvesting samples such as cells or tissue including skin tissue for use in research and therapeutic protocols. Kits and methods for deploying grafts, constructs or other products for therapeutic use are also provided. Use of the kits temporarily preserves the viability and/or function of the sample (such as a tissue sample) and/or therapeutic agent.
    Type: Application
    Filed: August 22, 2018
    Publication date: February 28, 2019
    Applicant: PolarityTE, Inc.
    Inventors: Denver Lough, Edward Swanson
  • Publication number: 20190046691
    Abstract: Provided herein are constructs of micro-aggregate multicellular, minimally polarized grafts containing Leucine-rich repeat-containing G-protein coupled Receptor (LGR) expressing cells for wound therapy applications, tissue engineering, cell therapy applications, regenerative medicine applications, medical/therapeutic applications, tissue healing applications, immune therapy applications, and tissue transplant therapy applications which preferably are associated with a delivery vector/substrate/support/scaffold for direct application.
    Type: Application
    Filed: October 19, 2018
    Publication date: February 14, 2019
    Applicant: PolarityTE, Inc.
    Inventor: Denver Lough
  • Patent number: D894729
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: September 1, 2020
    Assignee: PolarityTE, Inc.
    Inventors: Denver Lough, Edward Swanson